All Industries

Sonus faber Chooses SPARK Microsystems’ UWB Wireless Tech for Low Latency Home Audio Speakers

SPARK Microsystems

SPARK Microsystems, a Canadian fabless semiconductor company specializing in next-generation short-range wireless communications, today announced Italian speaker manufacturer Sonus faber has chosen SPARK’s UWB technology for its Duetto wireless speaker system. SPARK’s UWB technology enables low latency data transmission from wired to wireless speakers, allowing Sonus faber to deliver a high-quality, uncompressed audio performance that can’t be achieved with Bluetooth or Wi-Fi. Sonus faber’s new Duetto speaker system enables customers to enjoy their Duetto streaming home audio system with the satellite speaker of the stereo pair being connected to the main unit using the SPARK UWB-based solution. The system supports a range up to 8 meters for unfettered placement/positioning flexibility with no compromises in audio performance. The system, certified by ETSI and the Federal Communications Commission, enables customers to enjoy high precision wireless connectivity between speakers, maximizing placement options whilst enjoying market leading functionality and integration of music services and connectivity. “Sonus faber’s Duetto speaker system demonstrates the market’s evolutionary shift to true wireless audio that delivers premium sound without the wires,” said Julie Delamarre, SPARK Microsystems, Vice President of EMEA Sales. “The Duetto speaker system is based on SPARK’s UWB technology that enables low latency, deterministic, low power, and high-speed data transport, allowing Sonus faber to deliver uncompressed audio across wirelessly-linked speakers – an industry first achievement.” The ultra-low power, low latency and high-throughput SPARK UWB wireless transceiver enables a new class of short-range wireless connectivity for premium audio applications. Offering higher data rates and better robustness than other short-range wireless solutions – with extreme low latency that can’t be matched with Bluetooth or WiFi – SPARK UWB enables high fidelity uncompressed audio for a richer, more immersive audio experience. “SPARK’s UWB technology was chosen for the Duetto speaker system because of its capabilities to deliver uncompressed audio wirelessly with no latency, variability or bandwidth concerns,” said Livio Cucuzza, Chief Design Officer, Sonus faber. “These capabilities will give our customers a superior experience because they can enjoy audio as it was originally intended by the artists themselves, with the flexibility of wireless pairing between speakers.” About Sonus faber Sonus faber is a designer and manufacturer of high-end audio technology, founded in 1983 in Italy’s Veneto region, world-renowned for luxury goods manufacturing. Latin for “Artisan of Sound”, Sonus faber expertly informs their state-of-the-art audio engineering with the traditions of Italian design expertise, hand-producing speakers with design cues inspired by centuries of musical instruments, crafted from organic materials such as wood and leather to reproduce sound as the artist intended. Marrying the artisanal beauty of the past with the technology of the future, Sonus faber audio systems deliver natural, immersive, three-dimensional sound from beautiful, hand-designed speakers built to last for decades. For more information, please visit www.sonusfaber.com. About SPARK Microsystems SPARK Microsystems is building next generation short-range wireless communication devices. SPARK provides high data rate and very low latency wireless communication links at an ultra-low power profile, making it ideal for personal area networks (PANs) used in mobile, consumer and IoT-connected products. Leveraging patented technologies, SPARK Microsystems strives to minimize and ultimately eliminate wires and batteries from a wide range of applications while delivering a wired-like performance. For more information, please visit www.sparkmicro.com. Contact Details Jenna Beaucage +1 508-340-6851 jbeaucage@rainierco.com Company Website https://www.sparkmicro.com

October 05, 2023 10:08 AM Eastern Daylight Time

BLUETTI Exclusive Autumn Prime Day Offer: Significant Savings on Power Stations Available in Canada

500NewsWire

Toronto, ON, Oct 5, 2023 ( 500NewsWire ) -- As the leaves turn brilliant hues and the air gets crisper, it's time to gear up for the autumn season. BLUETTI, a leading name in portable power stations, is here to ensure you're fully prepared for whatever autumn throws your way. From October 5th to 20th, BLUETTI is rolling out its Autumn Prime Day promotion, offering astounding savings of up to C$1,699 on its lineup of power stations. Whether you're safeguarding your home against unexpected power outages or planning to enjoy the great outdoors during this beautiful season, BLUETTI has got your back. Modular Home Battery Systems AC300+B300 now C$3,799, was C$4,598, save C$799 AC500+B300S now C$4,999, was C$5,699, save C$700 Nothing is scarier than no power. The AC300+B300 and AC500+B300S modular systems are built to ensure you never face power outage horrors again. With responsive UPS functions, these systems supply power to essential loads within 20 milliseconds. Everything from TVs to refrigerators to fish tanks is running uninterrupted, even your sensitive computers are safe from data loss. Beyond guarding your house, they also harness free solar energy and low-cost grid power to keep your bills low. With their modularity, you can add battery packs as needed to have a scalable capacity: 3,072Wh~12,288Wh for AC300, and 3,072Wh~18,432Wh for AC500. Choose between the AC300 and AC500 based on your energy needs and budget. If you’re a high-power consumer, the 5,000W AC500 is more suitable than the 3,000W AC300. Additionally, the AC500 system performs smoothly at temperatures as low as -20°C due to its B300S’s self-heating feature. Portable Generators for Adventure AC60 now C$699, was C$899, save C$200 EB3A now C$279, was C$399, save C$120 Heading into the wild for some weekend camping or outdoor escapades? Look no further than the BLUETTI AC60. This rugged power station is built to withstand water and dust, making it the ultimate adventure companion. Sporting a 403Wh battery, it can charge your 16Wh camera 21 times or keep a 12Wh lamp glowing for a remarkable 28 hours. Need more juice? Add the B80 battery pack for 2,015Wh of total power. During the sale, BLUETTI also offers significant savings on the EB series, including the EB3A, EB55, and EB70S. These portable generators are both convenient and powerful, powering all your gadgets outdoors. When paired with BLUETTI’s portable solar panels such as the PV120 and PV200, they continuously provide power everywhere the journey takes you. All-around Power Stations AC200MAX now C$1,899, was C$2,599, save C$700 (Oct 10-Oct 11) AC180 now C$1,049, was C$1,499, save C$450 (Oct 10-Oct 20) For those seeking an ultimate all-in-one solution for both indoor and outdoor power needs, BLUETTI's AC series has you covered. The AC200MAX and AC180 offer compact packages with ample energy storage. The AC200MAX, the cream of the crop, delivers a robust 2,200W output from its 2,048Wh LFP battery, making it an ideal power source for RV road trips, camping adventures, off-grid living, and those pesky power outages. It's expandable too–simply add extra batteries, like the B230 and B300, for extended use. Meanwhile, the AC180 is lighter at 16.4kg and packs a punch with its 1,152Wh capacity. It dishes out a steady 1,800W of continuous power, handling most home appliances with ease. Its Power Lifting mode even allows it to power resistive heating elements under 2,700W, perfect for tools like heat guns and electric kettles. Although it accepts a slightly lower 500W of solar input compared to the AC200MAX's 900W, it's still swift to recharge using solar panels, such as BLUETTI's efficient PV350 and PV420. When autumn storms roll in and the wind howls, having a reliable backup power source can make all the difference. BLUETTI's power stations are designed to ensure your home remains cozy and well-lit and your outdoor experience is full of energy. Don't miss out on these incredible offers, and get ready to enhance your fall season and beyond with BLUETTI! About BLUETTI BLUETTI has been committed to promoting sustainability and green energy solutions since its inception. By offering eco-friendly energy storage solutions for both indoor and outdoor use, BLUETTI aims to provide exceptional experiences for our homes while also contributing to a sustainable future for our planet. This commitment to sustainable energy has helped BLUETTI expand its reach to over 100 countries and gain the trust of millions of customers worldwide. For more information, please visit BLUETTI online at https://www.bluettipower.ca/. Social Media Presence: Facebook Instagram Twitter YouTube Contact Details Amanda Yan - Integrated Marketing, BLUETTI pr@bluetti.com Company Website https://www.bluettipower.ca/

October 05, 2023 10:00 AM Eastern Daylight Time

Image

WISeKey International Holding AG: Comprehensive Financial & Growth Strategy Analysis by BestGrowthStocks.Com

WISeKey

NEW YORK, NY / NewsDirect / October 5th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive analysis on WISeKey International Holding AG a global leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company. WISeKey International Holding AG (NASDAQ: WKEY) is forming a constellation of 80 nanosatellites, 17 of which have been launched via SpaceX. Best Growth Stock's full report breaks through the noise and offers a full comprehensive and easy-to-understand analysis of WISeKey’s stock movement, recent events, earnings, growth strategy and more. Access this full report: https://bestgrowthstocks.com/access-wkey-analysis/ (copy and paste to browser may be required) About WISeKey: WISeKey International Holding Ltd ("WISeKey", SIX: WIHN; Nasdaq: WKEY) is a global leader in cybersecurity, digital identity, and IoT solutions platform. It operates as a Swiss-based holding company through several operational subsidiaries, each dedicated to specific aspects of its technology portfolio. The subsidiaries include (i) SEALSQ Corp (Nasdaq: LAES), which focuses on semiconductors, PKI, and post-quantum technology products, (ii) WISeKey SA which specializes in RoT and PKI solutions for secure authentication and identification in IoT, Blockchain, and AI, (iii) WISeSat AG which focuses on space technology for secure satellite communication, specifically for IoT applications, and (iv) WISe.ART Corp which focuses on trusted blockchain NFTs and operates the WISe.ART marketplace for secure NFT transactions. Each subsidiary contributes to WISeKey's mission of securing the internet while focusing on their respective areas of research and expertise. Their technologies seamlessly integrate into the comprehensive WISeKey platform. WISeKey secures digital identity ecosystems for individuals and objects using Blockchain, AI, and IoT technologies. With over 1.6 billion microchips deployed across various IoT sectors, WISeKey plays a vital role in securing the Internet of Everything. The company's semiconductors generate valuable Big Data that, when analyzed with AI, enable predictive equipment failure prevention. Trusted by the OISTE/WISeKey cryptographic Root of Trust, WISeKey provides secure authentication and identification for IoT, Blockchain, and AI applications. The WISeKey Root of Trust ensures the integrity of online transactions between objects and people. For more information on WISeKey's strategic direction and its subsidiary companies, please visit www.wisekey.com. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Media Contact Best Growth Stocks Steve Macalbry, Senior Editor Editor@BestGrowthStocks.com SOURCE: BestGrowthStocks.Com Contact Details Best Growth Stocks Steve Macalbry Editor@bestgrowthstocks.com

October 05, 2023 09:55 AM Eastern Daylight Time

Image

News Release

Thrive Global BioSafety Inc. changes name to Thrive Precision Health Inc.

Thrive Precision Health, Inc.

Thrive pivots to focus on applying technology to diabetes care. Spokane, WA USA – TheNewswire - October 5, 2023 – Thrive Global Biosafety Inc. (with subsidiary Thrive Testing and Biosafety Inc., "CNER" or "Company") (OTC:CNER) announced today it has completed a name change of the Company to Thrive Precision Health, Inc. Thrive Precision Health has two wholly subsidiary companies. The first subsidiary is Thrive Testing and Biosafety Inc., and the second is called Thrive Precision Health, Inc., incorporated under the State of Hawaii, will be renamed Thrive Precision Health (USA), Inc. While the focus has shifted to diabetes care, the core technology Thrive has licensed and is developing will change how care is delivered to diabetic patients. About Thrive Precision Health Inc. Thrive Precision Health, Inc. (“Thrive”) is building a global diabetes care powerhouse. We are acquiring established healthcare clinics that already specialize in diabetes care and bringing in three cutting-edge technologies to make them even better. Our goal is to provide top-notch care to patients worldwide with a seamless digital experience. Imagine if your healthcare was as unique as you are. We use AI and quantum biosensors to analyze data down to the molecular level, tailoring treatments and recommendations specifically for you. This means no more one-size-fits-all solutions. Your health decisions will be based on your personal data, ensuring you receive the most effective and personalized care possible. Leveraging this groundbreaking technology and clinical services will include Wound Care, Neuropathy Care, PIR diabetes care through advanced infusion methods, and conventional and complementary treatment to improve patient outcomes. All services will be performed within a biosafety-secured facility using our biodefense technology to protect our suspectable patients and staff from bacterial and viral infections. Important Notice Regarding Forward-Looking Statements This press release contains statements that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements, other than statements of present or historical fact included in this press release, regarding the Company's future financial performance, as well as the Company's strategy, future operations, revenue guidance, projected costs, prospects, plans, and objectives of management are forward-looking statements. When used in this press release, the words "could," "should," "will," "may," "believe," "anticipate," "intend," "estimate," "expect," "project," the negative of such terms and other similar expressions are intended to identify forward-looking statements. However, not all forward-looking statements contain such identifying words. These forward-looking statements are based on management's current expectations and assumptions about future events. They are based on currently available information about the outcome and timing of future events. Except as otherwise required by applicable law, the Company disclaims any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release. Nothing in this release is intended to be an offer of sale or purchase of any securities nor a solicitation of any offer for the sale or purchase of any securities. Thrive Precision Health, Inc. (formerly China New Energy Group Company) For more information: www.thriveprecision.health Contact: info@thrivebiosafety.com

October 05, 2023 09:51 AM Eastern Daylight Time

Minuteman Press Franchise Comes to Poundbury and Dorchester, Moves to Brand New Premises

Minuteman Press International Inc

Sprint Digital, Dorchester's leading small business printers, have successfully completed the transition into a Minuteman Press franchise. Owners David and Juanita Prince have relocated from their town centre premises, shared with the Dorchester Post Office, into their own stand alone premises in Poundbury at 13 & 14 Jubilee Court, Paceycombe Way. David Prince said, “With easy access and free parking, the offices just down from the Buttermarket are well placed for access for our clients. We will also continue to deliver to our existing business customers in Dorchester should they need to ensure a seamless transition for our clients.” Operating for over 50 years to serve local business communities, Minuteman Press International has almost 1000 independently owned and operated franchise locations worldwide. The transition from Sprint Digital to Minuteman Press will give small businesses in Dorchester, Poundbury and its surrounds more access to an extremely wide range of print solutions, from business cards and fliers to small signage, branded promotional items and much more. In response to the rebranding, David and Juanita stated, "The move to Minuteman Press will allow our print business to grow offering the businesses of Dorchester, Poundbury and its surrounds a quality affordable print solution. We are also inviting businesses to shop locally knowing that the product is as environmentally sourced as possible and supported by the expertise of world's leading print franchise.” Mark Jones, Regional VP of Minuteman Press International added, "We are excited to be working with David and Juanita, helping them to grow their franchise whilst supporting the local community with all their print requirements." As part of the conversion David Prince has reaffirmed that MMP Dorchester will take over Sprint Digital's sponsorship of the Dorchester Ladies football team into the 2023/24 season and they will continue to support the developers of Dorchesters Bike Park by providing a range of print solutions for their promotional needs. For more information on Minuteman Press in Dorchester and Poundbury, call 01305 264171 or visit their website: https://minuteman.com/uk/locations/england/dorchester/ Minuteman Press provides digital print, design, promotional products and services to businesses. Today they are much more than just print. They can provide anything you can put a name, image or logo on! Minuteman Press International was once again rated the #1 Printing & Marketing Services Franchise in the printing industry by Entrepreneur Magazine in 2023. This is the 32nd time overall and 20th straight year that they have achieved this stellar rating. Learn more about Minuteman Press franchise opportunities and read Minuteman Press franchise reviews at http://minutemanpressfranchise.co.uk Contact Details Minuteman Press International Chris Biscuiti +1 631-249-1370 cbiscuiti@mpihq.com Company Website https://minutemanpressfranchise.com

October 05, 2023 09:38 AM Eastern Daylight Time

Image

Tiziana Advances Phase 2 Site Selection for Its Lead Clinical Program in Non-Active Secondary Progressive Multiple Sclerosis (SPMS) and The Company Prepares for Six-Month Clinical Data Update

Benzinga

By Rachael Green, Benzinga Tiziana Life Sciences Ltd. (NASDAQ: TLSA) recently announced the Company has initiated site selection for its lead intranasal anti-CD3 monoclonal antibody drug candidate “foralumab” program entering Phase 2a clinical testing in non-active Secondary Progressive Multiple Sclerosis (na-SPMS) patients. In total, the multi-center clinical trial will have six to ten new clinical trial sites across the US. According to the Company, another key data milestone is expected soon at the ECTRIMS conference, which will detail the results from the expanded access program after six months of treatment. Investors should take note, as this is a significant event for the company through providing six-month clinical results on the second cohort of four patients (numbers 3-6), and also providing a PET scan which shows neuroinflammation in the brain (microglia). ECTRIMS is the world’s largest research meeting in multiple sclerosis and will be held October 11-13 in Milan, Italy. Tiziana also recently announced the acceptance of a publication in the prestigious journal Proceedings of the National Academy of Sciences (PNAS) of its study validating the mechanism of action (MoA) using intranasally administered foralumab in Alzheimer’s disease (AD). The published study concluded that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)”, which further supports the Company’s hypothesis for the use of foralumab in neurodegenerative disease. Key highlights from the Journal included: The authors conclude that “nasal anti-CD3 has the potential to be a non-toxic novel immunotherapeutic approach for the treatment of Alzheimer’s disease (AD)” FDA has cleared the IND for intranasal foralumab, a fully human anti-CD3 monoclonal antibody, for human study in mild to moderate Alzheimer’s Disease The publication shows anti-CD3 monoclonal antibody (mAb) administered intranasally, ameliorates disease in a 3xTg model of Alzheimer’s disease by targeting microglial activation in the brain, while expanding regulatory T cells in the periphery Remarkably, this reduced microglial activation and improved cognition occurs independent of amyloid beta disposition. The full publication can be found HERE Tiziana’s Foralumab Is A Promising Treatment With Potential To Treat Multiple Neurological Diseases “The anti-CD3 target is established and it’s validated,” said Tiziana COO and CMO Mathew Davis at a recent conference. “We are the only company that is delivering this intranasally. We are the only company that is in the clinic with a fully human anti-CD3 antibody.” The anti-CD3 monoclonal antibody used in Tiziana’s Foralumab binds to the CD3 receptor on the surface of T cells, typically used as a way to suppress the immune system to prevent transplant rejection or treat autoimmune disease. The challenge in treating these kinds of conditions has long been finding the balance between suppressing the immune response to protect the patient without harming the body’s ability to fight off actual threats like viral infections and bacteria. However, research shows that anti-CD3 antibodies can do just that. They are able to selectively dampen the autoimmune response – when the dysregulated immune system attacks the body’s own cells and tissue – without limiting its ability to detect and respond to external threats. The promising new treatment approach has already sparked interest from pharmaceutical industry leaders like Sanofi SA (NASDAQ: SNY), which just acquired an anti-CD3 therapy being developed for type 1 diabetes in a $2.9 billion acquisition of Provention Bio, Inc. Tiziana’s Foralumab is the only anti-CD3 monoclonal antibody treatment in clinical trials that is fully human — a significant differentiator as these tend to come with fewer adverse reactions than those that are genetically engineered. It’s also the only one that’s delivered via an intranasal spray, making it less invasive than an infusion and allowing it to travel directly to the T cells in the patient’s lymph nodes. In the neurological diseases that Tiziana is focused on, this formulation has allowed its lead drug candidate to bind to regulatory T cells, then these T cells activate and create Tregs which are specifically tasked with maintaining homeostasis and preventing the immune system from attacking itself. Once Foralumab creates these Tregs, they can cross through the blood-brain barrier and help fight neuroinflammation at its source. Tiziana Highlights Past Results And Upcoming Milestones Across Foralumab Clinical Trials During a recent investor conference, Davis focused on the exciting results Tiziana has seen so far from its clinical trials and highlighted some of the upcoming milestones and plans for the year ahead. Its lead program is in non-active secondary progressive multiple sclerosis (SPMS), a more severe stage of the debilitating disease that currently has no FDA-approved treatment. Instead, the standard of care typically involves treating the patient with Ocrelizumab, an anti-CD20 monoclonal antibody sold under the brand name Ocrevus by Genentech, a subsidiary of Hoffmann-La Roche AG (OTCQX: RHHBY). But the drug is not always as effective for SPMS patients as it is for other forms of MS. In fact, Davis noted that all of the patients in its clinical trials had previously tried Ocrelizumab and discontinued it when their symptoms continued to progress. In its ongoing expanded access program, for example, the Tiziana COO and CMO spoke about a patient who had discontinued the anti-CD20 treatment in 2021 when his condition had become so bad that he could no longer walk more than 100 feet without assistance. The non-active SPMS patient enrolled in Tiziana’s expanded access program in January 2022. “By the end of 2022, he was able to walk without assistance,” Davis said. “He’s back in his job and, as of this recording, he continues to walk without assistance.” In the biopharma’s most recent data readout, other patients from the expanded access program started to show similar improvement. Three of the four patients currently enrolled saw their fatigue scores decrease after three months. Meanwhile, a phase 1 trial found that microglia – a part of the innate immune system inside the brain – had significantly decreased activation in the brains of 5 out of 6 treated patients after three months. Davis said another data readout is expected soon, detailing the results from the expanded access program after six months of treatment. Tiziana has begun clinical site selection and plans to start a phase 2a trial in non-active SPMS before the end of this year with topline data expected by the end of 2024. The clinical-stage biopharma is also investigating Foralumab for Alzheimer’s disease (AD), another progressive neurological disease with an urgent need for better treatment options. Tiziana just received FDA approval to begin a phase 2 study in AD, and the company plans to launch that trial in the first half of next year. A press release on the acceptance from the Proceedings of the National Academy of Sciences (PNAS) can be found HERE along with the full publication HERE titled “Nasal Administration of anti-CD3 monoclonal antibody (mAb) ameliorates disease in a mouse model of Alzheimer’s disease”. To learn more about Tiziana, click HERE This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 05, 2023 09:15 AM Eastern Daylight Time

Lithium Craze: Comparing Arianne Phosphate To Top Companies

Arianne Phosphate

By Meg Flippin, Benzinga From powering electric vehicles to storing solar and wind energy, lithium plays a critical role in the transition to a greener world. So it’s not surprising demand for Lithium-Iron-Phosphate (LFP) batteries is exploding – as are the market values of its key publicly traded producers. With energy and food prices still high and weather-related calamities occurring far too often, everyone from companies to consumers is looking for greener alternatives across the board. Electric vehicles have driven a lot of the demand, but lithium is also used in storing captured wind and solar for the power grid and residential solar power systems. LFPs Gaining Traction For years, North American EV makers relied on lithium-ion batteries made of lithium, cobalt and nickel to power this greener vision. But cobalt and nickel are scarce and expensive – not to mention controversial. Companies looking for an alternative have turned to LFPs. These batteries are highly stable, longer lasting, and more resistant to heat degradation. They also require less lithium. In 2022, about 737,000 tons of lithium was produced globally. That’s expected to increase to 964,000 tons in 2023, reaching 1.17 million tons by 2024. The LFP market is projected to exceed $50 billion by 2023. And, in a recent report, Wood Mackenzie predicted that lithium iron phosphate will become the leading battery chemistry for EVs by 2028. Beyond EVs, there’s another big opportunity for LFPs: energy storage systems and powerwalls. These are designed to store energy from solar or the grid to be used later. Some are portable while others are connected. Tesla, Inc. (NASDAQ: TSLA) is increasingly using LFPs in its energy storage products, which bodes well for the industry. Northern Exposure Evidently, this isn’t lost on investors, and many investors are watching publicly traded lithium companies keenly. Some of the key players include Albemarle Corp. ( NYSE: ALB ), Sociedad Química y Minera S.A. (NYSE: SQM), Ganfeng Lithium Co., Ltd. (OTCMKTS: GNENF) and Mineral Resources Ltd. (OTCMKTS: MALRY). But they aren’t cheap. Albemarle currently trades at around $168 per share. In dollar terms, that’s more expensive than General Motors (NYSE: GM), Ford (NYSE: F), and even Amazon (NASDAQ: AMZN). Meanwhile, SQM sports a $15.85 billion market valuation. Fortunately, there are cheaper ways to get exposure to the lithium battery market, such as through the miners that provide the minerals needed to make batteries. Arianne Phosphate (OTCMKTS: DRRSF), one such company hailing from Quebec, Canada, provides a key ingredient for LFP batteries and is cheaper than the aforementioned lithium stocks in dollar terms. But, as its phosphate is snapped up by producers of everything from EVs to solar storage systems, that may not be the case for long. Deposits Set it Apart Arianne’s Lac à Paul project in Quebec could become a key resource for manufacturers. The geology of the deposit is igneous and thus very rare, with less than 10% of all phosphate coming from ore bodies of this nature. Arianne’s deposit can produce a purer concentrate, higher than over 90% of the world’s phosphate. Further, aside from the phosphate content, Arianne reports that its deposit does not have any issues with deleterious elements (radioactive, heavy-metal) that are found in most of the world’s phosphates. From an ESG perspective, Arianne’s mine also adheres to strict environmental, social and corporate standards that set it aside from most other deposits. There is also pro-mining legislation that helps companies like Arianne. The White House’s American Battery Materials Initiative is aimed at securing a reliable and sustainable supply of critical minerals used for power, electricity, and EVs. Meanwhile, the Department of Energy is awarding $2.8 billion from the Bipartisan Infrastructure Bill to boost domestic manufacturing. Lastly, Quebec has shown itself to be aggressive in attracting and advancing battery initiatives and is expected to play a significant role in Arianne’s advancement. Judging by how the market is moving, LFPs could well be the future. A cheaper way to play this exploding market is with phosphate, of which Arianne appears to be a well-positioned producer. ARIANNE PHOSPHATE INC. ( www.arianne-inc.com ) owns the Lac à Paul phosphate deposit in Quebec, Canada. Fully permitted and shovel ready, the asset is among the world’s largest greenfield deposits, capable of producing an environmentally friendly phosphate concentrate. Due to the nature of its high-purity, low-contaminant product, Arianne’s phosphate can be used to produce fertilizer as well as meeting the technical requirements of specialty applications such as the lithium-iron-phosphate (LFP) battery. The Lac à Paul deposit is rare due to its geographic location and geological structure. Arianne Phosphate is listed on both the TSX-V: DAN and the OTCQX: DRRSF. This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. This information contains forward looking statements. All statements, other than statements of historical fact, included herein, including without limitation, statements regarding potential mineralisation and reserves, exploration results and future plans and objectives of Arianne Phosphate Inc, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Arianne Phosphate Inc’s (“Arianne Phosphate” or the “Company”) expectations are disclosed under the heading "Risk Factors" and elsewhere in Arianne Phosphate Inc’s documents filed from time-to-time with the TSX Venture and other regulatory authorities. Contact Details Brian Ostroff, President brian.ostroff@arianne-inc.com Company Website https://www.arianne-inc.com

October 05, 2023 09:15 AM Eastern Daylight Time

Are You Trading With Or Against the Market Makers?

TechniTrader

Most retail traders blame the Market Makers for their losses. The reality is that you are often trading against a Market Maker rather than with the trend of the market. To provide some background, I’ll give you a synopsis of one of my personal experiences with Market Makers. Many years ago, I walked into our trading offices to see my business and trading partner, Howard, on the phone laughing and joking as if it was his best buddy. He quickly jotted a note to me. I read it and jolted. “The Market Maker?” I whispered. He grinned. I was speechless. My trading partner was talking to a NYSE Market Maker during trading hours. How he managed that I will never know. After the conversation ended, Howard explained that he wanted to make sure that what we were going to teach in our first ever 2-day workshop was consistent with Market Maker strategies. The Market Maker not only thought that Howard’s new order type was brilliant, he asked if he could use it on his trading floor. I was more concerned that everybody already knew what we were teaching. But that worry dissipated 10 minutes into my live training in a room packed with professionals, retail day traders and retail investors. That was over 25 years ago. We still use that unique order type today for teaching students, both retail and professional traders. There have been a few minor tweaks but it still works amazingly. Howard’s novel order entry method is still being used by professionals today. There are other stories, but for now let’s talk about Market Makers. The Stock Market of the USA guarantees only ONE thing: for every buyer, there will be a seller and for every seller, there will be a buyer. That’s it. No promise of great, instant wealth. No promises of getting rich quick. When you trade, you need to understand the role of the Market Maker. The stock market is not a casino, it is a giant auction that Market Makers facilitate. There are 3 types of Market Making in today’s market structure: 1. Automated, Computer-Generated Make the Market Systems. The US exchange computers adjust the pricing of every US listed stock before the US stock market opens on the East Coast of the US at 9:30 ET. The goal of adjusting the pricing structure seconds ahead of open is to prevent any arbitrage between global stock markets for retail investors and retail traders. This is a fully automated system that has minimal human intervention. 2. HFT Maker/Takers and HFT Market Makers. High Frequency Trading, aka HFT, is automated programs that generate huge volumes of small-lot orders on the millisecond scale that convert to larger orders on the retail side's one-minute scale. HFTs have been part of the market since 2002. HFT algorithms are set up by humans but the orders are fully automated. The role of these HFTs is to provide liquidity to the exchanges. Illiquidity is a major problem for the exchanges. This is because of the Dark Pools, which are Alternative Transaction System (ATS) venues. About 80% of all liquidity is off the exchanges in ATS venues. In the past few years, the major exchanges have opened up ATS venues to ensure they have sufficient revenues. So they have become quite huge. 3. Major Banks and Giant Financial Services Companies Approved for Market Making. JP Morgan Chase, Goldman Sachs, Citadel (also the largest PFOF, Payment for Order Flow market maker–retail orders are sent to them from retail brokers) are the prominent Market Makers at this time. There are others, of course. They have huge trading floors with the most experienced, savvy and skilled traders in the world. Making the Market is required during stressed market conditions, when there is a VOID of buyers. Recently, the market has encountered a VOID of buyers. This is not illiquidity, it is not volatility, it is an absence of major market participant groups buying. The lack of buyers creates a void, an absence of buyers, which are necessary to complete order transactions. Market Makers fill that role by setting up Sell Short Orders at appropriate price levels for that day’s open based on overnight order flow data from retail brokers. When there is a void of buyers, Market Makers use short orders, which can be canceled automatically if conditions change, and then establish the buy-to-cover price. This is based upon technical and fundamental data in a graphical chart format. The orders are then automated to trigger as the market opens. IF you are chasing HFTs trying to sell short, you will lose money. The HFTs start buying to cover their short trades as soon as the stock gaps down at open. IF you are buying or selling ahead of the market open and you have not done your due diligence in determining the current Market Condition, which is a Platform Market Condition, you will lose money. (There are 6 major conditions.) Market Makers are not watching for your 100- to 1000-share order or stop loss to take you out and then smile about it. There are 30 – 40 million transactions every day in the US stock market. The reason you are losing money is because you are unaware of what is happening on the professional side of the market. You are trading against the professionals. How to solve this problem? Find trading education that helps you understand how the professionals trade. Look for a methodology that shows you how to identify their activity with the tools you already have. Visit my website to learn more about my unique approach to reading charts: Relational Technical Analysis. Martha Stokes, CMT https://www.technitrader.courses/ TechniTrader has been teaching traders and investors a complete process for trading or investing in the stock market and other financial markets since 1998. We have helped over 500,000 traders and investors achieve their financial goals. Our courses provide a complete, comprehensive training program based on a college-style curriculum that uses a tri-level approach to analyzing assets or derivatives to trade. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Mel Ainuu mel@technitrader.com Company Website https://www.technitrader.courses/

October 05, 2023 09:15 AM Eastern Daylight Time

Interactive Strength Works To Sign Binding Acquisition Agreement That Would Transform The Digital Fitness Company Into A Profitable, High-Growth Business Across B2B and B2C Markets

Benzinga

By Rachael Green, Benzinga Interactive Strength, Inc. (NASDAQ: TRNR), doing business as FORME, is currently working towards signing a definitive agreement to acquire a connected hardware “target” after announcing a non-binding letter of intent last month. The combined Company is projected to generate $10 million in 2023, more than $25 million in gross revenue in 2024, and is expected to be cashflow positive and adjusted EBITDA profitable by the fourth quarter of 2024. The potential transaction is expected to accelerate FORME’s commercialization path, result in immediate scale across all functions and create a high-growth and profitable platform that sells connected hardware/software fitness platform across B2B and B2C channels. The premium smart home gym and virtual personal training provider is aiming to execute a definitive acquisition agreement by the fourth quarter of this year. Here are some of the growth opportunities investors can look for as FORME works toward a binding agreement by the end of this year. The Potential Acquisition Would Create A Significantly Scaled Up Connected Fitness Equipment Business “We believe this will be a transformational acquisition that can accelerate our commercialization path,” said FORME Founder and CEO Trent Ward. “We expect this transaction can help us achieve immediate scale across all of our cost centers, resulting in a high-growth, profitable platform that sells connected fitness equipment and digital fitness services across B2B and B2C channels.” In addition to scaling FORME’s sales, engineering, logistics and other functions, the connected fitness acquisition would be a synergistic merger that would immediately create cross-selling opportunities across both FORME’s and the target’s customer base. It also has the potential to bring in a strong B2B distribution partner for FORME’s premium smart home gym equipment, allowing FORME to ramp up its commercialization efforts. Combined, FORME and the target acquisition are projected to bring in over $10 million in gross revenue for 2023 and over $25 million in for 2024, achieving both positive cash flow and positive adjusted EBITDA by the fourth quarter of next year. The Upside Potential Of FORME’s Transition To A B2B-Led Platform Right now, FORME primarily targets the B2C market, offering smart home gym equipment and a variety of virtual personal training plans directly to consumers. But as the rapid decline of Peloton (NASDAQ: PTON) suggests, that home fitness market just isn’t big enough to sustain long-term growth as post-pandemic consumers return to the gym. Peloton recently reported net losses of over $241 million for its fourth quarter, as sales and subscriptions continue to decline. FORME has a differentiated market strategy that addresses changing consumer habits and developed a flexible approach to its B2C segment. The Company offers both premium equipment and a range of monthly subscription options at different price points that offer live one-on-one coaching with a personal trainer through the user’s connected fitness mirror or their mobile device. But its biggest growth opportunity comes from its pivot into the B2B space, delivering its equipment and services to hotels, gyms and other enterprise customers that want to offer premium fitness options to their customers. FORME has already made some moves in this B2B channel but the potential acquisition, which is said to derive most of its sales from the B2B space, would dramatically increase its exposure to that more profitable, more scalable market. This would allow FORME to become a B2B-led platform while still maintaining and growing its B2C channel, potentially sidestepping the profitability challenges faced by Peloton and other B2C-focused companies in the connected fitness space. In an August report on FORME, Goldman Small Cap Research calls the digital fitness platform “a rare, high growth, low valuation firm offering significant upside potential.” Goldman cited the potential acquisition slated for the fourth quarter as well as the opportunity for similar deals in the future as FORME targets other acquisitions over the next few years. To watch a video with the product in action, CLICK HERE This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

October 05, 2023 09:15 AM Eastern Daylight Time

1 ... 662 663 664 665 666 ... 3517